Stay updated with breaking news from 45798520. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Integra LifeSciences (NASDAQ:IART – Get Free Report) was downgraded by research analysts at StockNews.com from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Friday. IART has been the topic of several other reports. JMP Securities cut their price target on shares of Integra LifeSciences from $65.00 […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) was the recipient of a large decrease in short interest in October. As of October 15th, there was short interest totalling 2,390,000 shares, a decrease of 5.5% from the September 30th total of 2,530,000 shares. Approximately 3.4% of the shares of the stock are sold short. […]
Integra LifeSciences (NASDAQ:IART – Free Report) had its price target reduced by Truist Financial from $41.00 to $39.00 in a report issued on Thursday, Benzinga reports. They currently have a hold rating on the life sciences company’s stock. Several other equities analysts have also issued reports on the stock. JMP Securities lowered their target price […]
Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report)’s share price gapped down before the market opened on Wednesday following a dissappointing earnings announcement. The stock had previously closed at $37.20, but opened at $35.04. Integra LifeSciences shares last traded at $35.02, with a volume of 115,455 shares trading hands. The life sciences company reported […]
Integra LifeSciences (NASDAQ:IART – Get Free Report) released its earnings results on Wednesday. The life sciences company reported $0.76 EPS for the quarter, missing the consensus estimate of $0.78 by ($0.02), Briefing.com reports. The business had revenue of $382.40 million for the quarter, compared to analysts’ expectations of $387.22 million. Integra LifeSciences had a net […]